Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Works of Thabo Lengana being referenced
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
2019
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thabo Lengana | 773 | 763 | 324 | 32 | 1.1k | |
| Kenneth L. Gage | 492 | 534 | 269 | 45 | 1.0k | |
| Susanne Lütje | 816 | 669 | 405 | 44 | 1.3k | |
| Norbert M. Blumstein | 664 | 678 | 261 | 24 | 1.3k | |
| Filippo Lodi | 822 | 751 | 243 | 44 | 1.4k | |
| Emre Demirci | 668 | 786 | 346 | 39 | 1.2k | |
| Paola Caroli | 463 | 482 | 332 | 37 | 860 | |
| D. Cobben | 767 | 566 | 245 | 41 | 1.3k | |
| Manabu Oguchi | 780 | 864 | 166 | 30 | 1.3k | |
| Michael K. Haseman | 581 | 690 | 168 | 27 | 1.0k | |
| Asim Afaq | 837 | 748 | 179 | 51 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...